Blood Based Cancer Diagnostics

Testing patients for cancer has typically involved a tissue biopsy – collecting the cells in question for closer examination. However, these tests can be invasive, risky, costly, and painful. Liquid biopsies, on the other hand, rely on analyzing bits of tumor material that are found in bodily fluids such as blood. This week we are exploring blood-based cancer diagnostics, which hold promise for improving patient care and finding tumors earlier in their development. Join us as we learn about blood-based cancer diagnostics and talk with experts in the field.




Each month our analyst team reviews an emerging trend with interested listeners — alternating between Healthcare and Agriculture — outlining macro-trends, industry sub-sectors, key influencers, market leaders, and potential investment opportunities. Register here.